Everolimus-Eluting Stents Versus Sirolimus- or Paclitaxel-Eluting Stents: Two-Year Results from the Guthrie Health Off-Label Stent (GHOST) Registry
Author:
Affiliation:
1. Guthrie Clinic; Sayre, Pennsylvania
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1540-8183.2013.12016.x/fullpdf
Reference33 articles.
1. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents;Stone;N Engl J Med,2007
2. Late stent thrombosis: Considerations and practical advice for the use of drug-eluting stents: A report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task Force;Hodgson;Catheter Cardiovasc Interv,2007
3. Late angiographic stent thrombosis (LAST) events with drug-eluting stents;Ong;J Am Coll Cardiol,2005
4. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents;Win;JAMA,2007
5. Four-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT II trial;Garg;Catheter Cardiovasc Interv,2011
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of Clinical Outcomes of Long Stent Implantation with First- and Second-Generation Drug-Eluting Stents Following Rotational Atherectomy;Soonchunhyang Medical Science;2022-06-30
2. Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial;Advances in Interventional Cardiology;2022
3. Impact of optimal preparation before drug-coated balloon dilatation for de novo lesion in patients with coronary artery disease;Cardiovascular Revascularization Medicine;2021-03
4. Comparison of Neointimal Response between Durable-Polymer Everolimus-Eluting Stent and Bioabsorbable-Polymer Everolimus-Eluting Stent for Severely Calcified Lesions Requiring Rotational Atherectomy;International Heart Journal;2020-07-30
5. Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis;Coronary Artery Disease;2019-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3